Teva Pharmaceutical Industries (TEVA)
(Delayed Data from NYSE)
$13.81 USD
+0.56 (4.23%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $13.80 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Brokerage Reports
0 items in cart
Teva Pharmaceutical Industries Ltd. [TEVA]
Reports for Purchase
Showing records 421 - 440 ( 453 total )
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Slew of new product launches likely to drive overall strong performance in CY12
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Slew of new product launches likely to drive overall strong performance in CY12..
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Near-term outlook remains bleak due to lack of FTF launches & delay in launch of an ‘undisclosed product’...
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Moderately revising downwards our CY11 estimates in view of dismal Q2CY11 performance
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Short term outlook remains bleak in view of ongoing manufacturing issues
Provider: FIRST GLOBAL
Analyst: THOMAS K